Michael P. Agius

Also affiliated with Boston University, Harvard University, Dana-Farber Cancer Institute, Parallel Consulting (United States), Massachusetts Institute of Technology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Pro-organic radical contrast agents (“pro-ORCAs”) for real-time MRI of pro-drug activation in biological systems”.

Pro-organic radical contrast agents (“pro-ORCAs”) for real-time MRI of pro-drug activation in biological systems

Polymer Chemistry(2020)10.1039/d0py00558d

N/A

0.542DataRank · unranked

36 citations

Alexandre Detappe, Peter Harvey, Nolan M. Gallagher, C. Mathieu, Michael P. Agius +9 more

Anti-MUC1-C Antibody–Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.06.069

N/A

0.489DataRank · unranked

25 citations

C. Mathieu, Caining Jin, Michael P. Agius, Marie‐Charlotte Diringer, Vu‐Long Tran +6 more

Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma

Nature Nanotechnology(2023)10.1038/s41565-022-01310-1

N/A

0DataRank · unranked

105 citations

Hung V.‐T. Nguyen, Yivan Jiang, Michael P. Agius, Wencong Wang, C. Mathieu +8 more